Small RNAs for treating bone cancer
Graduate student Brian Ell speaks about his research on using small RNAs to develop novel therapeutics for the treatment of bone metastatic cancer.
Ell is a 2013 Emerging Alumni Scholar. He is one of three distinguished graduate students recognized by the Alumni Council's Committee on Academic Programs for Alumni (CAPA). The annual program is designed to share with alumni some of the best doctoral research being conducted at the University.
The 2013 presentations will take place on Tuesday, April 30, at 7:30 p.m. in 219 Aaron Burr Hall.
Dissertation Title: MicroRNA regulation during breast cancer: Novel therapeutics and biomarkers for bone metastasis
Bio: Brian Ell grew up in Lakeville, Minnesota, and attended the University of Wisconsin, where he majored in Biochemistry and Genetics. After graduation, Brian worked for several years in the lab of Dr. Alan Rapraeger studying the mechanism behind the Syndecan-1 protein and cellular adhesion. This experience with basic research helped him realize that his interests skewed towards translational, disease-based research, motivating Brian to attend Princeton University in 2008 to begin his Ph.D. in Molecular Biology. Under the mentorship of Dr. Yibin Kang, Brian has examined the complex interplay between cancer cells and surrounding normal tissues, and has strengthened the understanding of the processes that cancer cells use to spread throughout the body.